InsidersTradesSigma
대한약품 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 대한약품 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 대한약품 has logged 139 reports. The latest transaction was reported on 16 July 2026 (Purchase). Among the most active insiders: 이윤우. The full history is accessible without an account.
139
Insider Decl.
n/a
Thresholds
€15,521
62 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 July 2026
Declarations139 total
25 of 139 declarations
About 대한약품
대한약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the manufacturing of pharmaceutical products and medications.